+454.2%
MRNA vs FN
+12.8%
+441.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.5% | -3.8% | -3.3% |
| 7D | -10.1% | +5.8% | -15.9% | -9.9% |
| 30D | +126.7% | -20.6% | +147.4% | +127.9% |
| 3M | +184.1% | -28.6% | +212.7% | +185.9% |
| 6M | +143.3% | -20.7% | +164.0% | +134.4% |
| YTD | +359.9% | -8.1% | +368.0% | +322.1% |
| 1Y | +454.2% | +13.3% | +440.9% | +361.9% |
| All | +454.2% | +12.8% | +441.4% | +361.9% |
Cumulative growth
Daily Returns
Daily percentage return beside FN.
Daily Out/Under-Performance
Portfolio return minus FN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling